LGALS3 and prostate cancer: Moreover, overexpression of galectin-3 has been reported in multiple types of human tumors, including: ovarian cancer [7]; pancreatic cancer [5, 6, 10, 11]; breast cancer [5, 10, 11]; thyroid, gastric and colon cancer [5, 7, 11]; hepatocellular, head and neck, prostate cancer, and glioma [10]; T lymphoma, Burkitt lymphoma, and cervical cancer [11].